04 Jan Psychopharmacology and Bio-psychosocial Considerations for Social Workers

SOCIAL WORK

SOCW 6443 –Psychopharmacology and Bio-psychosocial Considerations for Social Workers

Discussion: Neurobiology, Client Presentation, and Pharmacological Treatment Plans

 

• Developing appropriate pharmacological treatment plans requires medical and mental health professionals to consider all potential factors that may be contributing to the client’s psychopathology. Contributing factors may include family history of mental illness (Preston, O’Neal, & Talaga, 2010), personal history, life circumstances, and drug abuse. Additionally, neurotransmitter malfunctions (genetic or self-induced) may manifest as diagnosable mental illnesses. Mental health care teams (e.g., counselors, medical doctors, psychiatrists, psychologists, social workers, and support teams) need to consider all of these factors in diagnosing and treating psychopathology.

• For this Discussion, review the document “Neurobiology Considerations Case Study: Suzy” found in this week’s Learning Resources and consider the recommendations you might make to treat Suzy.

 

• By Day 3 (Note!!! PLEASE WRITE OUT EACH QUESTION BEFORE PROVIDING A RESPONSE. Foolow the prompt please.!!! “Please I need an excellent paper”

 

• Post a brief description of the possible pharmacological recommendations for treating Suzy. Explain any neurobiological considerations that inform your recommendations. Explain the benefits and limitations of your recommendations. Justify your recommendations based on the Learning Resources and current literature.

 

Be sure to support your responses with specific references to the to the Learning resources. If you are using additional articles, be sure to provide full APA-formatted citations for your references both within the text and on the referencing section. PLEASE ALWAYS INCLUDE THE REQIRED TEXTBOOK as part of the references and if possible some of the REQUIRED READING if applicable. Please always start by referring to THE TEXTBOOK, below

REQUIRED TEXTBOOK

Psychopharmacology Demystified 2011

Author: Lichtblau, Leonard

ISBN-13:

ISBN-10:

Edition/Copyright: 2011

Publisher: Cengage Learning

 

REQUIRED

Handbook of Clinical Psychopharmacology for Therapists 8TH 17

Author: Preston, John D.

ISBN-13: 978-1-62625-927-0

ISBN-10: 1-62625-927-5

Edition/Copyright: 8TH 17

Publisher: New Harbinger Pub.(cc)

 

Learning Resources

Required Readings

 

Lichtblau, L. (2011). Psychopharmacology demystified. Clifton Park, NY: Delmar, Cengage Learning.

• Chapter 1, “Neuroanatomy and Neurophysiology” (pp. 1–18)

Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017). Handbook of clinical psychopharmacology for therapists (8th ed.). Oakland, CA: New Harbinger.

• Chapter 3, “Neurobiology” (pp. 29–43)

• Chapter 4, “Pharmacology” (pp. 45–56)

• Chapter 9, “Anxiety Disorders” (pp. 107-122)

 

National Institute of Mental Health. (2016). Mental health medications: Overview. Retrieved from https://www.nimh.nih.gov/health/topics/mental-health-medications/index.shtml

 

National Institute of Neurological Disorders and Stroke. (2014). Brain basics: Understanding sleep. Retrieved on from http://www.ninds.nih.gov/disorders/brain_basics/understanding_sleep.htm#sleep_disorders

 

Document: Neurobiology Considerations Case Study: Suzy (PDF)

 

Use this case study for this Week‘s Discussion and Assignment as you prepare a treatment plan for Suzy.

 

Optional Resources

 

MSW home page

 

Use this link to access the MSW home page, which provides resources for your social work program.